Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases

Keyphrases

• Rare Diseases 100%
• Drug Repurposing 100%
• Clinical Research 66%
• Multinational Trial 66%
• Counseling 33%
• Peer-reviewed Publication 33%
• Regulatory Requirements 33%
• Existing Resources 33%
• Public Funding 33%
• Research Infrastructure 33%
• Administrative Burden 33%
• Tender 33%
• Drug Supply 33%
• Drug Stability 33%
• Rare Disease Patients 33%
• Multinational Clinical Trials 33%
• Rare Disease Drugs 33%

Medicine and Dentistry

• Rare Disease 100%
• Drug Repositioning 100%
• Clinical Research 50%
• Clinical Trial 25%
• Clinician 25%
• Counseling 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Rare Disease 100%
• Drug Repositioning 100%
• Clinical Research 50%
• Clinical Trial 25%
• Drug Stability 25%